Literature DB >> 16280610

The epidemiology of severe Streptococcus pyogenes associated disease in Europe.

T L Lamagni1, A Efstratiou, J Vuopio-Varkila, A Jasir, C Schalén.   

Abstract

Several European countries reported outbreaks of severe disease caused by Streptococcus pyogenes in the late 1980s. This marked a departure from the previous decades, where very few such outbreaks were noted. These changes in disease occurrence formed part of a global phenomenon, the reasons for which have yet to be explained. Results of surveillance activities for invasive S. pyogenes infection within Europe over the past fifteen years identified further increases in many countries. However, variations in surveillance methods between countries preclude robust comparisons being made, illustrating the need for a unified surveillance strategy across Europe. This was finally embodied in the Strep-EURO programme, introduced in 2002.

Entities:  

Mesh:

Year:  2005        PMID: 16280610

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  30 in total

1.  Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010.

Authors:  Chris Stockmann; Krow Ampofo; Adam L Hersh; Anne J Blaschke; Brian A Kendall; Kent Korgenski; Judy Daly; Harry R Hill; Carrie L Byington; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2012-04-24       Impact factor: 9.079

2.  Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland.

Authors:  Tuula Siljander; Outi Lyytikäinen; Susanna Vähäkuopus; Petrus Säilä; Jari Jalava; Jaana Vuopio-Varkila
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

3.  Invasive group A streptococcal infection in children: clinical manifestations and molecular characterization in a French pediatric tertiary care center.

Authors:  S Henriet; F Kaguelidou; P Bidet; M Lorrot; A De Lauzanne; S Dauger; F Angoulvant; J-C Mercier; C Alberti; E Bingen; A Faye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03       Impact factor: 3.267

4.  emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development.

Authors:  Andrew C Steer; Graham Magor; Adam W J Jenney; Joseph Kado; Michael F Good; David McMillan; Michael Batzloff; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2009-06-10       Impact factor: 5.948

Review 5.  Prescribing for people with acute rheumatic fever.

Authors:  Anna P Ralph; Sara Noonan; Claire Boardman; Catherine Halkon; Bart J Currie
Journal:  Aust Prescr       Date:  2017-04-03

6.  Necrotising fasciitis in the North East of Scotland: a 10-year retrospective review.

Authors:  D W Neilly; M Smith; A Woo; V Bateman; I Stevenson
Journal:  Ann R Coll Surg Engl       Date:  2019-03-11       Impact factor: 1.891

7.  Clinical characteristics of children with group A streptococcal toxic shock syndrome admitted to pediatric intensive care units.

Authors:  Antonio Rodríguez-Nuñez; Silvia Dosil-Gallardo; Iolanda Jordan
Journal:  Eur J Pediatr       Date:  2010-10-28       Impact factor: 3.183

8.  emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years?

Authors:  Roberta Creti; Monica Imperi; Lucilla Baldassarri; Marco Pataracchia; Simona Recchia; Giovanna Alfarone; Graziella Orefici
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

9.  Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007.

Authors:  Andrew C Steer; Adam Jenney; Joseph Kado; Michael F Good; Michael Batzloff; Lepani Waqatakirewa; E Kim Mullholland; Jonathan R Carapetis
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

10.  Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004.

Authors:  Theresa L Lamagni; Shona Neal; Catherine Keshishian; Neelam Alhaddad; Robert George; Georgia Duckworth; Jaana Vuopio-Varkila; Androulla Efstratiou
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.